Esophageal Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Esophageal Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Novel Strategy for Early Detection of Esophageal Squamous Cell Carcinoma [NA]
This clinical trial update reports that a study at University of California, San Francisco is actively recruiting to evaluate a novel strate…
-
CLINICAL_TRIALS research · 2025-03-26Clinical Trial Update: A Study to Investigate the Safety, Pharmacokinetics, and Clinical Activity of AP203 in Patients with Locally Advanced or Metastatic Solid Tumors, and Expansion to Selected Malignancies [Phase 1, Phase 2]
An ongoing Phase 1/2 clinical trial evaluating AP203 in patients with locally advanced or metastatic solid tumors, including non-small cell …
-
CLINICAL_TRIALS research · 2025-03-25Clinical Trial Update: Efficacy and Safety of Cadonilimab and Chemoradiotherapy in Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma [NA]
This clinical trial update describes a study of cadonilimab in combination with chemoradiotherapy for unresectable locally advanced esophage…
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: Prospective Phase II Clinical Study of Neoadjuvant Chemoradiotherapy Combined With PD-1/PD-L1 Inhibitors in the Treatment of Locally Advanced Resectable Esophageal Squamous Cell Carcinoma [Phase 2]
This document describes a prospective Phase II study evaluating neoadjuvant chemoradiotherapy combined with PD-1/PD-L1 inhibitors for locall…
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: A Multicenter Cancer Biospecimen Collection Study
A multicenter cancer biospecimen collection trial sponsored by Cofactor Genomics is currently recruiting, covering multiple cancer indicatio…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-03-11Clinical Trial Update: Total Neoadjuvant Therapy Combined With Adebrelimab in Locally Advanced Resectable ESCC [Phase 2, Phase 3]
A clinical trial update evaluating total neoadjuvant therapy combined with the PD-1 inhibitor adebrelimab for locally advanced resectable es…
-
CLINICAL_TRIALS research · 2025-03-07Clinical Trial Update: A Multicenter Trial of YSQTG vs. Simulated Agents With Neoadjuvant Chemoradiotherapy or Chemoimmunotherapy for EC [NA]
A multicenter trial is evaluating YSQTG versus simulated agents with neoadjuvant chemoradiotherapy or chemoimmunotherapy for esophageal squa…
-
CLINICAL_TRIALS research · 2025-03-06Clinical Trial Update: Chemoradiotherapy Followed by Planned Surgery or by Surveillance and Surgery Only When Needed for Oesophageal Cancer [Phase 3]
A Phase 3 trial comparing chemoradiotherapy followed by planned surgery versus surveillance with surgery only if needed for esophageal squam…
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: QL1706 in Combination With Neoadjuvant Chemotherapy Versus Neoadjuvant Chemotherapy for Locally Advanced, Resectable Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 trial evaluating QL1706 in combination with neoadjuvant chemotherapy versus neoadjuvant chemotherapy alone for locally advanced, res…
-
CLINICAL_TRIALS research · 2025-02-14Clinical Trial Update: The Neoadjuvant Treatment Modalities in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma (NEO-EC）
A registered clinical trial investigating neoadjuvant treatment modalities for locally advanced esophageal squamous cell carcinoma.
-
CLINICAL_TRIALS research · 2025-01-22Clinical Trial Update: AK112 Combined With Chemotherapy as the First-line Treatment in Advanced Esophageal Squamous Cell Carcinoma Patients [Phase 2]
A Phase 2 trial is evaluating AK112 in combination with chemotherapy as first-line therapy for advanced esophageal squamous cell carcinoma a…
-
CLINICAL_TRIALS research · 2025-01-03Clinical Trial Update: Safety and Efficacy Study of Pulsed Electric Field (PEF) Therapy in Patients With Advanced or Unresectable Esophageal Squamous Cell Carcinoma [NA]
This clinical trial assesses the safety and efficacy of Pulsed Electric Field therapy for advanced or unresectable esophageal squamous cell …
-
CLINICAL_TRIALS research · 2024-12-24Clinical Trial Update: Efficacy and Safety of QL1706 Plus Lenvatinib As 2nd Line Theapy in Patients with Metastatic Esophageal Carcinoma After Disease Progression on ICIs Therapy [Phase 1, Phase 2]
Clinical trial evaluating QL1706 plus lenvatinib as second-line therapy for metastatic esophageal squamous cell carcinoma after progression …
-
CLINICAL_TRIALS research · 2024-12-03Clinical Trial Update: Low-Dose Involved-Field Radiotherapy Plus Immunochemotherapy for ESCC [Phase 2]
Phase 2 clinical trial evaluating low-dose involved-field radiotherapy plus immunochemotherapy for esophageal squamous cell carcinoma; curre…
-
CLINICAL_TRIALS research · 2024-12-02Clinical Trial Update: Sacituzumab Govitecan for Advanced Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 trial evaluating sacituzumab govitecan for advanced esophageal squamous cell carcinoma is currently recruiting.
-
CLINICAL_TRIALS research · 2024-11-29Clinical Trial Update: Tumor Regression Grade As Predictor of Adjuvant Therapy
Clinical trial investigating tumor regression grade as a predictor of adjuvant therapy in esophageal squamous cell carcinoma. The study is c…
-
CLINICAL_TRIALS research · 2024-11-25Clinical Trial Update: Tislelizumab Combined with Chemotherapy and All Trans Retinoic Acid for Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma [Phase 2]
A Phase 2 clinical trial protocol investigates tislelizumab combined with chemotherapy and all-trans retinoic acid for locally advanced or m…
-
CLINICAL_TRIALS research · 2024-11-25Clinical Trial Update: Influence Mechanism of Tumor Microenvironment Changes on Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma
A clinical trial investigating how tumor microenvironment changes influence the effectiveness of neoadjuvant therapy for esophageal squamous…
-
CLINICAL_TRIALS research · 2024-11-21Clinical Trial Update: Trilaciclib for the Prevention of Chemoradiotherapy-Induced Myelosuppression in Esophageal Squamous Cell Carcinoma
Clinical trial update indicates ongoing recruitment for trilaciclib to prevent chemoradiotherapy-induced myelosuppression in esophageal squa…
-
CLINICAL_TRIALS research · 2024-11-18Clinical Trial Update: Combination of Tislelizumab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-002) [Phase 2]
Phase 2 clinical trial evaluating the combination of tislelizumab with chemoradiotherapy for esophageal squamous cell carcinoma; the study i…
-
CLINICAL_TRIALS research · 2024-11-15Clinical Trial Update: Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975) [Phase 3]
This is a Phase 3 trial (MK-3475-975/KEYNOTE-975) evaluating pembrolizumab versus placebo in combination with chemotherapy and radiotherapy …
-
CLINICAL_TRIALS research · 2024-11-15Clinical Trial Update: Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of IPM514 in Patients with Esophageal Squamous Cell Carcinoma [EARLY_Phase 1]
An early-phase (Phase 1) trial evaluating IPM514 in Esophageal Squamous Cell Carcinoma to assess safety, tolerability, pharmacokinetics, and…
-
CLINICAL_TRIALS research · 2024-11-14Clinical Trial Update: A Study of Chemoradiation in Combination with Tislelizumab As First Line Treatment in Participants with Advanced Esophageal Squamous Cell Carcinoma [Phase 3]
A Phase 3 clinical trial is evaluating chemoradiation in combination with tislelizumab as first-line therapy for advanced Esophageal Squamou…
-
CLINICAL_TRIALS research · 2024-11-14Clinical Trial Update: Prediction of Lymph Node Status in Stage T1 Esophageal Squamous Cell Carcinoma（RENMIN-237）
A clinical trial update for RENMIN-237 focusing on predicting lymph node status in stage T1 Esophageal Squamous Cell Carcinoma.
-
CLINICAL_TRIALS research · 2024-11-12Clinical Trial Update: Study of Dalpiciclib Isethionate Plus Pyrotinib Maleate in the Treatment of Advanced Esophageal Squamous Cell Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating the combination of dalpiciclib isethionate and pyrotinib maleate for advanced esophageal squamous cell c…